Document and Entity Information
Document and Entity Information - shares shares in Thousands | 6 Months Ended | |
Mar. 31, 2018 | Apr. 20, 2018 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2018 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | AAPL | |
Entity Registrant Name | APPLE INC | |
Entity Central Index Key | 320,193 | |
Current Fiscal Year End Date | --09-29 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 4,915,138 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Income Statement [Abstract] | ||||
Net sales | $ 61,137 | $ 52,896 | $ 149,430 | $ 131,247 |
Cost of sales | 37,715 | 32,305 | 92,096 | 80,480 |
Gross margin | 23,422 | 20,591 | 57,334 | 50,767 |
Operating expenses: | ||||
Research and development | 3,378 | 2,776 | 6,785 | 5,647 |
Selling, general and administrative | 4,150 | 3,718 | 8,381 | 7,664 |
Total operating expenses | 7,528 | 6,494 | 15,166 | 13,311 |
Operating income | 15,894 | 14,097 | 42,168 | 37,456 |
Other income/(expense), net | 274 | 587 | 1,030 | 1,408 |
Income before provision for income taxes | 16,168 | 14,684 | 43,198 | 38,864 |
Provision for income taxes | 2,346 | 3,655 | 9,311 | 9,944 |
Net income | $ 13,822 | $ 11,029 | $ 33,887 | $ 28,920 |
Earnings per share: | ||||
Basic (in dollars per share) | $ 2.75 | $ 2.11 | $ 6.69 | $ 5.50 |
Diluted (in dollars per share) | $ 2.73 | $ 2.10 | $ 6.63 | $ 5.46 |
Shares used in computing earnings per share: | ||||
Basic (in shares) | 5,024,877 | 5,225,791 | 5,068,877 | 5,262,226 |
Diluted (in shares) | 5,068,493 | 5,261,688 | 5,113,140 | 5,294,841 |
Cash dividends declared per share (in dollars per share) | $ 0.63 | $ 0.57 | $ 1.26 | $ 1.14 |
CONDENSED CONSOLIDATED STATEME3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 13,822 | $ 11,029 | $ 33,887 | $ 28,920 |
Other comprehensive income/(loss): | ||||
Change in foreign currency translation, net of tax effects of $8, $(44), $7 and $32, respectively | 263 | 214 | 303 | (161) |
Change in unrealized gains/losses on derivative instruments: | ||||
Change in fair value of derivatives, net of tax benefit/(expense) of $(64), $(25), $(130) and $(253), respectively | (27) | (300) | 61 | 1,168 |
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $77, $311, $56 and $100, respectively | (207) | (1,032) | (105) | (726) |
Total change in unrealized gains/losses on derivative instruments, net of tax | (234) | (1,332) | (44) | 442 |
Change in unrealized gains/losses on marketable securities: | ||||
Change in fair value of marketable securities, net of tax benefit/(expense) of $541, $(256), $1,005 and $733, respectively | (2,003) | 464 | (2,849) | (1,344) |
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $(7), $7, $34 and $(4), respectively | 29 | (13) | (46) | 7 |
Total change in unrealized gains/losses on marketable securities, net of tax | (1,974) | 451 | (2,895) | (1,337) |
Total other comprehensive income/(loss) | (1,945) | (667) | (2,636) | (1,056) |
Total comprehensive income | $ 11,877 | $ 10,362 | $ 31,251 | $ 27,864 |
CONDENSED CONSOLIDATED STATEME4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Parenthetical) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Statement of Comprehensive Income [Abstract] | ||||
Change in foreign currency translation, tax effects | $ 8 | $ (44) | $ 7 | $ 32 |
Change in fair value of derivatives, tax benefit/(expense) | (64) | (25) | (130) | (253) |
Adjustment for net (gains)/losses realized and included in net income, tax expense/(benefit) | 77 | 311 | 56 | 100 |
Change in fair value of marketable securities, tax benefit/(expense) | 541 | (256) | 1,005 | 733 |
Adjustment for net (gains)/losses realized and included in net income, tax expense/(benefit) | $ (7) | $ 7 | $ 34 | $ (4) |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Current assets: | ||
Cash and cash equivalents | $ 45,059 | $ 20,289 |
Short-term marketable securities | 42,881 | 53,892 |
Accounts receivable, less allowances of $60 and $58, respectively | 14,324 | 17,874 |
Inventories | 7,662 | 4,855 |
Vendor non-trade receivables | 8,084 | 17,799 |
Other current assets | 12,043 | 13,936 |
Total current assets | 130,053 | 128,645 |
Long-term marketable securities | 179,286 | 194,714 |
Property, plant and equipment, net | 35,077 | 33,783 |
Other non-current assets | 23,086 | 18,177 |
Total assets | 367,502 | 375,319 |
Current liabilities: | ||
Accounts payable | 34,311 | 49,049 |
Accrued expenses | 26,756 | 25,744 |
Deferred revenue | 7,775 | 7,548 |
Commercial paper | 11,980 | 11,977 |
Current portion of long-term debt | 8,498 | 6,496 |
Total current liabilities | 89,320 | 100,814 |
Deferred revenue, non-current | 3,087 | 2,836 |
Long-term debt | 101,362 | 97,207 |
Other non-current liabilities | 46,855 | 40,415 |
Total liabilities | 240,624 | 241,272 |
Commitments and contingencies | ||
Shareholders’ equity: | ||
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 4,943,282 and 5,126,201 shares issued and outstanding, respectively | 38,044 | 35,867 |
Retained earnings | 91,898 | 98,330 |
Accumulated other comprehensive income/(loss) | (3,064) | (150) |
Total shareholders’ equity | 126,878 | 134,047 |
Total liabilities and shareholders’ equity | $ 367,502 | $ 375,319 |
CONDENSED CONSOLIDATED BALANCE6
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowances | $ 60 | $ 58 |
Common stock, par value (in dollars per share) | $ 0.00001 | $ 0.00001 |
Common stock, shares authorized (in shares) | 12,600,000,000 | 12,600,000,000 |
Common stock, shares issued (in shares) | 4,943,282,000 | 5,126,201,000 |
Common stock, shares outstanding (in shares) | 4,943,282,000 | 5,126,201,000 |
CONDENSED CONSOLIDATED STATEME7
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions | 6 Months Ended | |
Mar. 31, 2018 | Apr. 01, 2017 | |
Statement of Cash Flows [Abstract] | ||
Cash and cash equivalents, beginning of the period | $ 20,289 | $ 20,484 |
Operating activities: | ||
Net income | 33,887 | 28,920 |
Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 5,484 | 5,319 |
Share-based compensation expense | 2,644 | 2,473 |
Deferred income tax expense/(benefit) | (34,235) | 2,822 |
Other | (151) | (209) |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | 3,523 | 4,183 |
Inventories | (2,807) | (778) |
Vendor non-trade receivables | 9,715 | 4,512 |
Other current and non-current assets | (1,053) | (896) |
Accounts payable | (13,220) | (6,862) |
Deferred revenue | 478 | (221) |
Other current and non-current liabilities | 39,158 | 541 |
Cash generated by operating activities | 43,423 | 39,804 |
Investing activities: | ||
Purchases of marketable securities | (48,449) | (99,821) |
Proceeds from maturities of marketable securities | 31,884 | 12,429 |
Proceeds from sales of marketable securities | 38,942 | 60,454 |
Payments for acquisition of property, plant and equipment | (7,005) | (6,309) |
Payments made in connection with business acquisitions, net | (305) | (67) |
Other | 53 | (10) |
Cash generated by/(used in) investing activities | 15,120 | (33,324) |
Financing activities: | ||
Proceeds from issuance of common stock | 327 | 273 |
Payments for taxes related to net share settlement of equity awards | (1,190) | (788) |
Payments for dividends and dividend equivalents | (6,529) | (6,134) |
Repurchases of common stock | (32,851) | (18,012) |
Proceeds from issuance of term debt, net | 6,969 | 10,975 |
Repayments of term debt | (500) | 0 |
Change in commercial paper, net | 1 | 1,879 |
Cash used in financing activities | (33,773) | (11,807) |
Increase/(Decrease) in cash and cash equivalents | 24,770 | (5,327) |
Cash and cash equivalents, end of the period | 45,059 | 15,157 |
Supplemental cash flow disclosure: | ||
Cash paid for income taxes, net | 6,340 | 6,878 |
Cash paid for interest | $ 1,356 | $ 1,007 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Apple Inc. and its wholly-owned subsidiaries (collectively “Apple” or the “Company”) designs, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company’s products and services include iPhone ® , iPad ® , Mac ® , Apple Watch ® , AirPods ® , Apple TV ® , HomePod™, a portfolio of consumer and professional software applications, iOS, macOS ® , watchOS ® and tvOS™ operating systems, iCloud ® , Apple Pay ® and a variety of other accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store ® , App Store ® , Mac App Store, TV App Store, iBooks Store ® and Apple Music ® (collectively “Digital Content and Services”). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its retail and online stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers. Basis of Presentation and Preparation The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2017 (the “ 2017 Form 10-K”). The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. The first quarter of 2018 spanned 13 weeks, whereas a 14th week was added to the first fiscal quarter of 2017, as is done every five or six years, to realign the Company’s fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Share-Based Compensation During the first quarter of 2018, the Company adopted the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Update (“ASU”) No. 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which modified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. Historically, excess tax benefits or deficiencies from the Company’s equity awards were recorded as additional paid-in capital in its Condensed Consolidated Balance Sheets and were classified as a financing activity in its Condensed Consolidated Statements of Cash Flows. Beginning in 2018, the Company records any excess tax benefits or deficiencies from its equity awards as part of the provision for income taxes in its Condensed Consolidated Statements of Operations in the reporting periods in which equity vesting occurs. The Company elected to apply the cash flow classification requirements related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to cash generated by operating activities in the Condensed Consolidated Statements of Cash Flows of $225 million for the six months ended April 1, 2017 . Earnings Per Share The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (net income in millions and shares in thousands): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Numerator: Net income $ 13,822 $ 11,029 $ 33,887 $ 28,920 Denominator: Weighted-average basic shares outstanding 5,024,877 5,225,791 5,068,877 5,262,226 Effect of dilutive securities 43,616 35,897 44,263 32,615 Weighted-average diluted shares 5,068,493 5,261,688 5,113,140 5,294,841 Basic earnings per share $ 2.75 $ 2.11 $ 6.69 $ 5.50 Diluted earnings per share $ 2.73 $ 2.10 $ 6.63 $ 5.46 |
Financial Instruments
Financial Instruments | 6 Months Ended |
Mar. 31, 2018 | |
Investments, All Other Investments [Abstract] | |
Financial Instruments | Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash and available-for-sale securities by significant investment category as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 9,934 $ — $ — $ 9,934 $ 9,934 $ — $ — Level 1 (1) : Money market funds 5,742 — — 5,742 5,742 — — Mutual funds 800 — (105 ) 695 — 695 — Subtotal 6,542 — (105 ) 6,437 5,742 695 — Level 2 (2) : U.S. Treasury securities 56,737 1 (932 ) 55,806 6,379 9,106 40,321 U.S. agency securities 5,539 — (39 ) 5,500 2,837 588 2,075 Non-U.S. government securities 8,247 88 (137 ) 8,198 — 477 7,721 Certificates of deposit and time deposits 7,266 — — 7,266 4,611 2,021 634 Commercial paper 17,417 — — 17,417 15,455 1,962 — Corporate securities 138,036 176 (1,975 ) 136,237 101 27,431 108,705 Municipal securities 973 — (11 ) 962 — 166 796 Mortgage- and asset-backed securities 19,966 9 (506 ) 19,469 — 435 19,034 Subtotal 254,181 274 (3,600 ) 250,855 29,383 42,186 179,286 Total $ 270,657 $ 274 $ (3,705 ) $ 267,226 $ 45,059 $ 42,881 $ 179,286 September 30, 2017 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 7,982 $ — $ — $ 7,982 $ 7,982 $ — $ — Level 1 (1) : Money market funds 6,534 — — 6,534 6,534 — — Mutual funds 799 — (88 ) 711 — 711 — Subtotal 7,333 — (88 ) 7,245 6,534 711 — Level 2 (2) : U.S. Treasury securities 55,254 58 (230 ) 55,082 865 17,228 36,989 U.S. agency securities 5,162 2 (9 ) 5,155 1,439 2,057 1,659 Non-U.S. government securities 7,827 210 (37 ) 8,000 9 123 7,868 Certificates of deposit and time deposits 5,832 — — 5,832 1,142 3,918 772 Commercial paper 3,640 — — 3,640 2,146 1,494 — Corporate securities 152,724 969 (242 ) 153,451 172 27,591 125,688 Municipal securities 961 4 (1 ) 964 — 114 850 Mortgage- and asset-backed securities 21,684 35 (175 ) 21,544 — 656 20,888 Subtotal 253,084 1,278 (694 ) 253,668 5,773 53,181 194,714 Total $ 268,399 $ 1,278 $ (782 ) $ 268,895 $ 20,289 $ 53,892 $ 194,714 (1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. (2) Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company’s long-term marketable securities generally range from one to five years . The following tables show information about the Company’s marketable securities that had been in a continuous unrealized loss position for less than 12 months and for 12 months or greater as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Continuous Unrealized Losses Less than 12 Months 12 Months or Greater Total Fair value of marketable securities $ 159,198 $ 37,266 $ 196,464 Unrealized losses $ (2,633 ) $ (1,072 ) $ (3,705 ) September 30, 2017 Continuous Unrealized Losses Less than 12 Months 12 Months or Greater Total Fair value of marketable securities $ 101,986 $ 8,290 $ 110,276 Unrealized losses $ (596 ) $ (186 ) $ (782 ) The Company typically invests in highly rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. As of March 31, 2018 , the Company does not consider any of its investments to be other-than-temporarily impaired. Derivative Financial Instruments The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months . To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency–denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges. The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. The Company may enter into interest rate swaps, options or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 31, 2018 are expected to be recognized within 10 years . The Company may enter into foreign currency swaps to manage currency risk on its foreign currency–denominated term debt. These instruments may offset a portion of the foreign currency remeasurement gains or losses on the Company’s term debt and related interest payments. The Company designates these instruments as cash flow hedges. The Company’s hedged term debt–related foreign currency transactions as of March 31, 2018 are expected to be recognized within 24 years . Cash Flow Hedges The effective portions of cash flow hedges are recorded in accumulated other comprehensive income/(loss) (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into other income/(expense), net in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. Net Investment Hedges The effective portions of net investment hedges are recorded in other comprehensive income/(loss) (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. Fair Value Hedges Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. Non-Designated Derivatives Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three- and six-month periods ended March 31, 2018 , respectively, the Company recognized losses of $203 million and $142 million in net sales, losses of $247 million and $212 million in cost of sales and losses of $331 million and $373 million in other income/(expense), net. During the three- and six-month periods ended April 1, 2017 , respectively, the Company recognized a loss of $67 million and a gain of $206 million in net sales, a loss of $253 million and a gain of $79 million in cost of sales and a loss of $76 million and a gain of $432 million in other income/(expense), net. The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company’s derivative instruments at gross fair value as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) : Foreign exchange contracts $ 1,361 $ 290 $ 1,651 Interest rate contracts $ 12 $ — $ 12 Derivative liabilities (2) : Foreign exchange contracts $ 651 $ 514 $ 1,165 Interest rate contracts $ 1,052 $ — $ 1,052 September 30, 2017 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) : Foreign exchange contracts $ 1,049 $ 363 $ 1,412 Interest rate contracts $ 218 $ — $ 218 Derivative liabilities (2) : Foreign exchange contracts $ 759 $ 501 $ 1,260 Interest rate contracts $ 303 $ — $ 303 (1) The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets and other non-current assets in the Condensed Consolidated Balance Sheets. (2) The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses and other non-current liabilities in the Condensed Consolidated Balance Sheets. The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Gains/(Losses) recognized in OCI – effective portion: Cash flow hedges: Foreign exchange contracts $ 37 $ (317 ) $ 190 $ 1,410 Interest rate contracts — 2 1 9 Total $ 37 $ (315 ) $ 191 $ 1,419 Net investment hedges: Foreign currency debt $ (33 ) $ (85 ) $ (31 ) $ 37 Gains/(Losses) reclassified from AOCI into net income – effective portion: Cash flow hedges: Foreign exchange contracts $ 287 $ 1,344 $ 163 $ 833 Interest rate contracts 2 (2 ) 3 (3 ) Total $ 289 $ 1,342 $ 166 $ 830 Gains/(Losses) on derivative instruments: Fair value hedges: Interest rate contracts $ (674 ) $ (50 ) $ (948 ) $ (922 ) Gains/(Losses) related to hedged items: Fair value hedges: Fixed-rate debt $ 674 $ 50 $ 948 $ 922 The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 September 30, 2017 Notional Amount Credit Risk Amount Notional Amount Credit Risk Amount Instruments designated as accounting hedges: Foreign exchange contracts $ 48,122 $ 1,361 $ 56,156 $ 1,049 Interest rate contracts $ 35,250 $ 12 $ 33,000 $ 218 Instruments not designated as accounting hedges: Foreign exchange contracts $ 61,179 $ 290 $ 69,774 $ 363 The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values in its Condensed Consolidated Balance Sheets. As of March 31, 2018 , the net cash collateral posted by the Company related to derivative instruments under its collateral security arrangements was $241 million , which was recorded as other current assets in the Condensed Consolidated Balance Sheet. As of September 30, 2017 , the net cash collateral received by the Company related to derivative instruments under its collateral security arrangements was $35 million , which was recorded as accrued expenses in the Condensed Consolidated Balance Sheet. Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. As of March 31, 2018 and September 30, 2017 , the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $2.1 billion and $1.4 billion , respectively, resulting in a net derivative liability of $313 million and a net derivative asset of $32 million , respectively. Accounts Receivable Trade Receivables The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized businesses and education, enterprise and government customers. The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk. In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. These credit-financing arrangements are directly between the third-party financing company and the end customer. As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. The Company had no customers that individually represented 10% or more of total trade receivables as of March 31, 2018 . As of September 30, 2017 , the Company had two customers that individually represented 10% or more of total trade receivables, each of which accounted for 10% . The Company’s cellular network carriers accounted for 48% and 59% of total trade receivables as of March 31, 2018 and September 30, 2017 , respectively. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. As of March 31, 2018 , the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 44% , 20% and 11% . As of September 30, 2017 , the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 42% , 19% and 10% . |
Condensed Consolidated Financia
Condensed Consolidated Financial Statement Details | 6 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Condensed Consolidated Financial Statement Details | Condensed Consolidated Financial Statement Details The following tables show the Company’s condensed consolidated financial statement details as of March 31, 2018 and September 30, 2017 (in millions): Inventories March 31, September 30, Components $ 5,186 $ 3,025 Finished goods 2,476 1,830 Total inventories $ 7,662 $ 4,855 Property, Plant and Equipment, Net March 31, September 30, Land and buildings $ 14,931 $ 13,587 Machinery, equipment and internal-use software 57,784 54,210 Leasehold improvements 7,787 7,279 Gross property, plant and equipment 80,502 75,076 Accumulated depreciation and amortization (45,425 ) (41,293 ) Total property, plant and equipment, net $ 35,077 $ 33,783 Other Non-Current Liabilities March 31, September 30, Long-term taxes payable $ 34,913 $ 257 Deferred tax liabilities 548 31,504 Other non-current liabilities 11,394 8,654 Total other non-current liabilities $ 46,855 $ 40,415 Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Interest and dividend income $ 1,505 $ 1,282 $ 2,957 $ 2,506 Interest expense (792 ) (530 ) (1,526 ) (1,055 ) Other expense, net (439 ) (165 ) (401 ) (43 ) Total other income/(expense), net $ 274 $ 587 $ 1,030 $ 1,408 |
Income Taxes
Income Taxes | 6 Months Ended |
Mar. 31, 2018 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which significantly changed U.S. tax law. The Act lowered the Company’s U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018, while also imposing a deemed repatriation tax on previously deferred foreign income. The Act also created a new minimum tax on certain future foreign earnings. During the first six months of fiscal 2018, the Company recognized income tax expense of $9.3 billion , of which $2.6 billion was a provisional estimate in accordance with the U.S. Securities and Exchange Commission Staff Accounting Bulletin No. 118 and was recognized during the first quarter of 2018. This $2.6 billion provisional estimate included $1.8 billion related to the impact of remeasuring to reduce the Company’s deferred tax balances to reflect the new tax rate, and approximately $800 million associated with the net impact of the deemed repatriation tax. Deferred Tax Balances As a result of the Act, the Company remeasured certain deferred tax assets and liabilities based on the revised rates at which they are expected to reverse, including items for which the related income tax effects were originally recognized in OCI. In addition, the Company elected to record certain deferred tax assets and liabilities related to the new minimum tax on certain future foreign earnings. The provisional estimate of $1.8 billion noted above incorporates assumptions based upon the best available interpretation of the Act and may change as the Company receives additional clarification and implementation guidance. During the second quarter of 2018, the FASB issued ASU No. 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”). ASU 2018-02 allows an entity to elect to reclassify the income tax effects of the Act on items within AOCI to retained earnings. The Company elected to apply the provision of ASU 2018-02 at the beginning of the second quarter of 2018 with a reclassification of net tax benefits related to cumulative foreign currency translation and unrealized gains/losses on derivative instruments and marketable securities, resulting in a $278 million decrease in AOCI and a corresponding increase in retained earnings in the Condensed Consolidated Balance Sheet. Deemed Repatriation Tax As of September 30, 2017, the Company had a U.S. deferred tax liability of $36.4 billion for deferred foreign income. As a result of the deemed repatriation tax, which is based on the Company’s cumulative post-1986 deferred foreign income, the Company replaced $36.1 billion of its U.S. deferred tax liability with a provisional tax payable of $38.0 billion . This estimate of the deemed repatriation tax is based, in part, on the amount of cash and other specified assets anticipated to be held by the Company’s foreign subsidiaries as of September 29, 2018. Therefore, the tax payable may change as the asset amounts are finalized. The Company plans to pay the tax in installments in accordance with the Act. Unrecognized Tax Benefits As of March 31, 2018 , the Company had gross unrecognized tax benefits of $9.5 billion . These gross unrecognized tax benefits have been offset by certain tax deposits and a $1.1 billion reduction for the estimated impact of the deemed repatriation tax, with the net unrecognized tax benefits classified as other non-current liabilities in the Condensed Consolidated Balance Sheet. Upon recognition, $8.2 billion of the unrecognized tax benefits would impact the Company’s effective tax rate. The Company had accrued $1.5 billion of gross interest and penalties as of March 31, 2018 , which are also classified as other non-current liabilities in the Condensed Consolidated Balance Sheet. The Company believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner inconsistent with its expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Although timing of resolution and/or closure of audits is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease (either by payment, release or a combination of both) in the next 12 months by as much as $3.4 billion . European Commission State Aid Decision On August 30, 2016, the European Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (the “State Aid Decision”). The State Aid Decision orders Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward. The Company believes the State Aid Decision to be without merit and appealed to the General Court of the Court of Justice of the European Union. Ireland has also appealed the State Aid Decision. Although Ireland is still computing the recovery amount, the Company expects the amount to be in line with the European Commission’s announced recovery amount of €13 billion , plus interest of €1 billion . During the third quarter of 2018, the Company expects to begin funding amounts into escrow, where they will remain pending conclusion of all appeals. The Company believes that any incremental Irish corporate income taxes potentially due related to the State Aid Decision would be creditable against U.S. taxes. |
Debt
Debt | 6 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Debt | Debt Commercial Paper The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of both March 31, 2018 and September 30, 2017 , the Company had $12.0 billion of Commercial Paper outstanding with maturities generally less than nine months . The weighted-average interest rate of the Company’s Commercial Paper was 1.68% as of March 31, 2018 and 1.20% as of September 30, 2017 . The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 31, 2018 and April 1, 2017 (in millions): Six Months Ended March 31, April 1, Maturities 90 days or less: Proceeds from/(Repayments of) commercial paper, net $ 4,070 $ (1,318 ) Maturities greater than 90 days: Proceeds from commercial paper 5,550 7,057 Repayments of commercial paper (9,619 ) (3,860 ) Proceeds from/(Repayments of) commercial paper, net (4,069 ) 3,197 Total change in commercial paper, net $ 1 $ 1,879 Term Debt As of March 31, 2018 , the Company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $111.1 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the U.S. dollar–denominated and Australian dollar–denominated floating-rate notes, semi-annually for the U.S. dollar–denominated, Australian dollar–denominated, British pound–denominated, Japanese yen–denominated and Canadian dollar–denominated fixed-rate notes and annually for the euro-denominated and Swiss franc–denominated fixed-rate notes. The following table provides a summary of the Company’s term debt as of March 31, 2018 and September 30, 2017 : Maturities March 31, 2018 September 30, 2017 Amount (in millions) Effective Interest Rate Amount (in millions) Effective Interest Rate 2013 debt issuance of $17.0 billion: Floating-rate notes 2018 2018 $ 2,000 1.10% 1.10 % $ 2,000 1.10% 1.10 % Fixed-rate 1.000% – 3.850% notes 2018 – 2043 12,500 1.08% – 3.91 % 12,500 1.08% – 3.91 % 2014 debt issuance of $12.0 billion: Floating-rate notes 2019 2019 1,000 2.09% 2.09 % 1,000 1.61% 1.61 % Fixed-rate 2.100% – 4.450% notes 2019 – 2044 8,500 2.09% – 4.48 % 8,500 1.61% – 4.48 % 2015 debt issuances of $27.3 billion: Floating-rate notes 2019 – 2020 1,537 1.87% – 2.12 % 1,549 1.56% – 1.87 % Fixed-rate 0.350% – 4.375% notes 2019 – 2045 25,094 0.28% – 4.51 % 24,522 0.28% – 4.51 % 2016 debt issuances of $24.9 billion: Floating-rate notes 2019 – 2021 1,350 1.93% – 3.05 % 1,350 1.45% – 2.44 % Fixed-rate 1.100% – 4.650% notes 2019 – 2046 23,120 1.13% – 4.78 % 23,645 1.13% – 4.78 % 2017 debt issuances of $28.7 billion: Floating-rate notes 2019 – 2022 3,250 1.88% – 2.30 % 3,250 1.38% – 1.81 % Fixed-rate 0.875% – 4.300% notes 2019 – 2047 25,786 1.54% – 4.30 % 25,705 1.51% – 4.30 % First quarter 2018 debt issuance of $7.0 billion: Fixed-rate 1.800% notes 2019 1,000 1.83 % — — % Fixed-rate 2.000% notes 2020 1,000 2.03 % — — % Fixed-rate 2.400% notes 2023 750 2.14 % — — % Fixed-rate 2.750% notes 2025 1,500 2.77 % — — % Fixed-rate 3.000% notes 2027 1,500 2.54 % — — % Fixed-rate 3.750% notes 2047 1,250 3.80 % — — % Total term debt 111,137 104,021 Unamortized premium/(discount) and issuance costs, net (236 ) (225 ) Hedge accounting fair value adjustments (1,041 ) (93 ) Less: Current portion of long-term debt (8,498 ) (6,496 ) Total long-term debt $ 101,362 $ 97,207 To manage interest rate risk on certain of its U.S. dollar–denominated fixed- or floating-rate notes, the Company has entered into interest rate swaps to effectively convert the fixed interest rates to floating interest rates or the floating interest rates to fixed interest rates on a portion of these notes. Additionally, to manage foreign currency risk on certain of its foreign currency–denominated notes, the Company has entered into foreign currency swaps to effectively convert these notes to U.S. dollar–denominated notes. A portion of the Company’s Japanese yen–denominated notes is designated as a hedge of the foreign currency exposure of the Company’s net investment in a foreign operation. As of March 31, 2018 and September 30, 2017 , the carrying value of the debt designated as a net investment hedge was $518 million and $1.6 billion , respectively. For further discussion regarding the Company’s use of derivative instruments see the Derivative Financial Instruments section of Note 2, “Financial Instruments.” The effective interest rates for the Notes include the interest on the Notes, amortization of the discount or premium and, if applicable, adjustments related to hedging. The Company recognized $742 million and $1.4 billion of interest expense on its term debt for the three- and six-month periods ended March 31, 2018 , respectively. The Company recognized $507 million and $1.0 billion of interest expense on its term debt for the three- and six-month periods ended April 1, 2017 , respectively. As of March 31, 2018 and September 30, 2017 , the fair value of the Company’s Notes, based on Level 2 inputs, was $111.1 billion and $106.1 billion , respectively. |
Shareholders' Equity
Shareholders' Equity | 6 Months Ended |
Mar. 31, 2018 | |
Equity [Abstract] | |
Shareholders' Equity | Shareholders’ Equity Share Repurchase Program As of March 31, 2018 , the Company had an authorized share repurchase program of up to $210 billion of the Company’s common stock, of which $199.6 billion had been utilized. The Company has entered, and in the future may enter, into accelerated share repurchase arrangements (“ASRs”) with financial institutions. In exchange for up-front payments, the financial institutions deliver shares of the Company’s common stock during the purchase periods of each ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, is determined at the end of the applicable purchase period of each ASR based on the volume-weighted average price of the Company’s common stock during that period. The shares received are retired in the periods they are delivered, and the up-front payments are accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheets in the periods the payments are made. The Company reflects the ASRs as a repurchase of common stock in the period delivered for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. The ASRs met all of the applicable criteria for equity classification, and therefore were not accounted for as derivative instruments. The following table shows the Company’s ASR activity and related information during the six months ended March 31, 2018 and the year ended September 30, 2017 : Purchase Period End Date Number of Shares (in thousands) Average Repurchase Price Per Share ASR Amount (in millions) November 2017 ASR February 2018 29,269 (1) $ 170.84 $ 5,000 August 2017 ASR November 2017 18,887 $ 158.84 $ 3,000 May 2017 ASR August 2017 20,108 $ 149.20 $ 3,000 February 2017 ASR May 2017 20,949 $ 143.20 $ 3,000 November 2016 ASR February 2017 51,157 $ 117.29 $ 6,000 August 2016 ASR November 2016 26,850 $ 111.73 $ 3,000 (1) Includes 23.6 million shares delivered and retired at the beginning of the purchase period, which began in the first quarter of 2018, and 5.7 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2018. Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: Number of Shares (in thousands) Average Repurchase Price Per Share Amount (in millions) 2018: Second quarter 137,040 $ 171.48 $ 23,500 First quarter 30,181 $ 169.26 5,109 Total open market common stock repurchases 167,221 $ 28,609 2017: Fourth quarter 29,073 $ 154.78 $ 4,500 Third quarter 30,356 $ 148.24 4,500 Second quarter 31,070 $ 128.74 4,001 First quarter 44,333 $ 112.78 5,000 Total open market common stock repurchases 134,832 $ 18,001 On May 1, 2018, the Company announced that the Board of Directors had authorized a new program to repurchase up to $100 billion of the Company’s common stock. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). |
Comprehensive Income
Comprehensive Income | 6 Months Ended |
Mar. 31, 2018 | |
Equity [Abstract] | |
Comprehensive Income | Comprehensive Income Comprehensive income consists of two components, net income and OCI. OCI refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s OCI consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and unrealized gains and losses on marketable securities classified as available-for-sale. The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended Comprehensive Income Components Financial Statement Line Item March 31, April 1, March 31, April 1, Unrealized (gains)/losses on derivative instruments: Foreign exchange contracts Net sales $ 87 $ (408 ) $ 271 $ (509 ) Cost of sales 21 (570 ) (6 ) (557 ) Other income/(expense), net (390 ) (367 ) (423 ) 237 Interest rate contracts Other income/(expense), net (2 ) 2 (3 ) 3 (284 ) (1,343 ) (161 ) (826 ) Unrealized (gains)/losses on marketable securities Other income/(expense), net 36 (20 ) (80 ) 11 Total amounts reclassified from AOCI $ (248 ) $ (1,363 ) $ (241 ) $ (815 ) The following table shows the changes in AOCI by component for the six months ended March 31, 2018 (in millions): Cumulative Foreign Currency Translation Unrealized Gains/Losses on Derivative Instruments Unrealized Gains/Losses on Marketable Securities Total Balances as of September 30, 2017 $ (354 ) $ (124 ) $ 328 $ (150 ) Other comprehensive income/(loss) before reclassifications 296 191 (3,854 ) (3,367 ) Amounts reclassified from AOCI — (161 ) (80 ) (241 ) Tax effect 7 (74 ) 1,039 972 Other comprehensive income/(loss) 303 (44 ) (2,895 ) (2,636 ) Cumulative effect of change in accounting principle (1) (176 ) 29 (131 ) (278 ) Balances as of March 31, 2018 $ (227 ) $ (139 ) $ (2,698 ) $ (3,064 ) (1) Refer to Note 4, “Income Taxes” for more information on the Company’s adoption of ASU 2018-02 at the beginning of the second quarter of 2018. |
Benefit Plans
Benefit Plans | 6 Months Ended |
Mar. 31, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Benefit Plans | Benefit Plans Stock Plans The Company had 270.0 million shares reserved for future issuance under its stock plans as of March 31, 2018 . Restricted stock units (“RSUs”) granted generally vest over four years , based on continued employment, and are settled upon vesting in shares of the Company’s common stock on a one -for-one basis. Each share issued with respect to RSUs granted under the Company’s stock plans reduces the number of shares available for grant under the plans by two shares. RSUs canceled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant under the plans utilizing a factor of two times the number of RSUs canceled or shares withheld. Rule 10b5-1 Trading Plans During the three months ended March 31, 2018 , Section 16 officers Angela Ahrendts, Timothy D. Cook, Luca Maestri, Daniel Riccio, Philip Schiller and Jeffrey Williams had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans. Restricted Stock Units A summary of the Company’s RSU activity and related information for the six months ended March 31, 2018 is as follows: Number of RSUs (in thousands) Weighted-Average Grant Date Fair Value Per RSU Aggregate Fair Value (in millions) Balance as of September 30, 2017 97,571 $ 110.33 RSUs granted 40,184 $ 159.25 RSUs vested (22,348 ) $ 103.66 RSUs canceled (3,023 ) $ 123.28 Balance as of March 31, 2018 112,384 $ 128.80 $ 18,856 The fair value as of the respective vesting dates of RSUs was $457 million and $3.6 billion for the three- and six-month periods ended March 31, 2018 , respectively, and was $460 million and $2.6 billion for the three- and six-month periods ended April 1, 2017 , respectively. Share-Based Compensation The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Cost of sales $ 257 $ 217 $ 509 $ 446 Research and development 666 575 1,312 1,164 Selling, general and administrative 425 425 823 863 Total share-based compensation expense $ 1,348 $ 1,217 $ 2,644 $ 2,473 The income tax benefit related to share-based compensation expense was $347 million and $1.0 billion for the three- and six-month periods ended March 31, 2018 , respectively, and was $424 million and $889 million for the three- and six-month periods ended April 1, 2017 , respectively. As of March 31, 2018 , the total unrecognized compensation cost related to outstanding RSUs and stock options was $11.4 billion , which the Company expects to recognize over a weighted-average period of 2.8 years . |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Accrued Warranty and Indemnification The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Beginning accrued warranty and related costs $ 4,323 $ 4,698 $ 3,834 $ 3,702 Cost of warranty claims (933 ) (1,031 ) (1,915 ) (2,368 ) Accruals for product warranty 640 1,068 2,111 3,401 Ending accrued warranty and related costs $ 4,030 $ 4,735 $ 4,030 $ 4,735 Agreements entered into by the Company sometimes include indemnification provisions which may subject the Company to costs and damages in the event of a claim against an indemnified third party. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to indemnification of third parties. The Company offers an iPhone Upgrade Program, which is available to customers who purchase a qualifying iPhone in the U.S., the U.K. and mainland China. The iPhone Upgrade Program provides customers the right to trade in that iPhone for a specified amount when purchasing a new iPhone, provided certain conditions are met. The Company accounts for the trade-in right as a guarantee liability and recognizes arrangement revenue net of the fair value of such right, with subsequent changes to the guarantee liability recognized within revenue. The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers of the Company and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. While the Company maintains directors and officers liability insurance coverage, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise. Concentrations in the Available Sources of Supply of Materials and Product Although most components essential to the Company’s business are generally available from multiple sources, a few components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that could materially adversely affect the Company’s financial condition and operating results. The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers decide to concentrate on the production of common components instead of components customized to meet the Company’s requirements. The Company has entered into agreements for the supply of many components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that could materially adversely affect its financial condition and operating results. Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia, with some Mac computers manufactured in the U.S. and Ireland. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are the sole-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s operating results could be adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s manufacturing purchase obligations typically cover its requirements for periods up to 150 days . Other Off–Balance Sheet Commitments Operating Leases The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The Company does not currently utilize any other off–balance sheet financing arrangements. As of March 31, 2018 , the Company’s total future minimum lease payments under noncancelable operating leases were $9.8 billion . The Company’s retail store and other facility leases typically have original terms not exceeding 10 years and generally contain multi-year renewal options. Unconditional Purchase Obligations The Company has entered into certain off–balance sheet arrangements which require the future purchase of goods or services (“unconditional purchase obligations”). The Company’s unconditional purchase obligations primarily consist of payments for supplier arrangements, internet and telecommunication services and intellectual property licenses. As of March 31, 2018 , the Company’s total future payments under noncancelable unconditional purchase obligations having a remaining term in excess of one year were $8.3 billion . Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, as further discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies for asserted legal and other claims, except for the following matter: VirnetX VirnetX, Inc. filed two lawsuits in the U.S. District Court for the Eastern District of Texas (the “Eastern Texas District Court”) against the Company alleging that certain Company products infringe four patents (the “VirnetX Patents”) relating to network communications technology (“VirnetX I” and “VirnetX II”). On September 30, 2016, a jury returned a verdict in VirnetX I against the Company and awarded damages of $302 million , which later increased to $440 million in post-trial proceedings. VirnetX I is currently on appeal at the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”). On April 11, 2018, a jury returned a verdict in VirnetX II against the Company and awarded damages of $503 million . VirnetX II is currently in post-trial proceedings and is expected to proceed to appeal thereafter. The Company has challenged the validity of the VirnetX Patents at the U.S. Patent and Trademark Office (the “PTO”). In response, the PTO has declared the VirnetX Patents invalid. VirnetX has appealed, and those appeals are currently pending at the Federal Circuit. The Federal Circuit has consolidated the Company’s appeal of the Eastern Texas District Court VirnetX I verdict and VirnetX’s appeals from the PTO invalidity proceedings. The Company believes it will prevail on the merits. The outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected. |
Segment Information and Geograp
Segment Information and Geographic Data | 6 Months Ended |
Mar. 31, 2018 | |
Segment Reporting [Abstract] | |
Segment Information and Geographic Data | Segment Information and Geographic Data The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments. The Company manages its business primarily on a geographic basis. The Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2017 Form 10-K. The Company evaluates the performance of its reportable segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the reportable segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes. The following table shows information by reportable segment for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Americas: Net sales $ 24,841 $ 21,157 $ 60,034 $ 53,125 Operating income $ 7,768 $ 6,668 $ 19,084 $ 17,162 Europe: Net sales $ 13,846 $ 12,733 $ 34,900 $ 31,254 Operating income $ 4,259 $ 3,851 $ 11,152 $ 9,587 Greater China: Net sales $ 13,024 $ 10,726 $ 30,980 $ 26,959 Operating income $ 4,963 $ 4,224 $ 11,871 $ 10,400 Japan: Net sales $ 5,468 $ 4,485 $ 12,705 $ 10,251 Operating income $ 2,346 $ 2,037 $ 5,428 $ 4,710 Rest of Asia Pacific: Net sales $ 3,958 $ 3,795 $ 10,811 $ 9,658 Operating income $ 1,278 $ 1,309 $ 3,853 $ 3,538 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 is as follows (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Segment operating income $ 20,614 $ 18,089 $ 51,388 $ 45,397 Research and development expense (3,378 ) (2,776 ) (6,785 ) (5,647 ) Other corporate expenses, net (1,342 ) (1,216 ) (2,435 ) (2,294 ) Total operating income $ 15,894 $ 14,097 $ 42,168 $ 37,456 |
Summary of Significant Accoun18
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Preparation | Basis of Presentation and Preparation The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2017 (the “ 2017 Form 10-K”). |
Fiscal Period | The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. The first quarter of 2018 spanned 13 weeks, whereas a 14th week was added to the first fiscal quarter of 2017, as is done every five or six years, to realign the Company’s fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years. |
New Accounting Pronouncements | During the first quarter of 2018, the Company adopted the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Update (“ASU”) No. 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which modified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. Historically, excess tax benefits or deficiencies from the Company’s equity awards were recorded as additional paid-in capital in its Condensed Consolidated Balance Sheets and were classified as a financing activity in its Condensed Consolidated Statements of Cash Flows. Beginning in 2018, the Company records any excess tax benefits or deficiencies from its equity awards as part of the provision for income taxes in its Condensed Consolidated Statements of Operations in the reporting periods in which equity vesting occurs. The Company elected to apply the cash flow classification requirements related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to cash generated by operating activities in the Condensed Consolidated Statements of Cash Flows of $225 million for the six months ended April 1, 2017 . During the second quarter of 2018, the FASB issued ASU No. 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”). ASU 2018-02 allows an entity to elect to reclassify the income tax effects of the Act on items within AOCI to retained earnings. The Company elected to apply the provision of ASU 2018-02 at the beginning of the second quarter of 2018 with a reclassification of net tax benefits related to cumulative foreign currency translation and unrealized gains/losses on derivative instruments and marketable securities, resulting in a $278 million decrease in AOCI and a corresponding increase in retained earnings in the Condensed Consolidated Balance Sheet. |
Fair Value Measurements | Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. |
Derivative Financial Instruments | Derivative Financial Instruments The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months . To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency–denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges. The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. The Company may enter into interest rate swaps, options or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 31, 2018 are expected to be recognized within 10 years . The Company may enter into foreign currency swaps to manage currency risk on its foreign currency–denominated term debt. These instruments may offset a portion of the foreign currency remeasurement gains or losses on the Company’s term debt and related interest payments. The Company designates these instruments as cash flow hedges. The Company’s hedged term debt–related foreign currency transactions as of March 31, 2018 are expected to be recognized within 24 years . Cash Flow Hedges The effective portions of cash flow hedges are recorded in accumulated other comprehensive income/(loss) (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into other income/(expense), net in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. Net Investment Hedges The effective portions of net investment hedges are recorded in other comprehensive income/(loss) (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. Fair Value Hedges Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. Non-Designated Derivatives Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. |
Segment Reporting | The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments. The Company manages its business primarily on a geographic basis. The Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2017 Form 10-K. The Company evaluates the performance of its reportable segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the reportable segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes. |
Summary of Significant Accoun19
Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Computation of Basic and Diluted Earnings Per Share | The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (net income in millions and shares in thousands): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Numerator: Net income $ 13,822 $ 11,029 $ 33,887 $ 28,920 Denominator: Weighted-average basic shares outstanding 5,024,877 5,225,791 5,068,877 5,262,226 Effect of dilutive securities 43,616 35,897 44,263 32,615 Weighted-average diluted shares 5,068,493 5,261,688 5,113,140 5,294,841 Basic earnings per share $ 2.75 $ 2.11 $ 6.69 $ 5.50 Diluted earnings per share $ 2.73 $ 2.10 $ 6.63 $ 5.46 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Investments, All Other Investments [Abstract] | |
Cash and Available-for-Sale Securities by Significant Investment Category | The following tables show the Company’s cash and available-for-sale securities by significant investment category as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 9,934 $ — $ — $ 9,934 $ 9,934 $ — $ — Level 1 (1) : Money market funds 5,742 — — 5,742 5,742 — — Mutual funds 800 — (105 ) 695 — 695 — Subtotal 6,542 — (105 ) 6,437 5,742 695 — Level 2 (2) : U.S. Treasury securities 56,737 1 (932 ) 55,806 6,379 9,106 40,321 U.S. agency securities 5,539 — (39 ) 5,500 2,837 588 2,075 Non-U.S. government securities 8,247 88 (137 ) 8,198 — 477 7,721 Certificates of deposit and time deposits 7,266 — — 7,266 4,611 2,021 634 Commercial paper 17,417 — — 17,417 15,455 1,962 — Corporate securities 138,036 176 (1,975 ) 136,237 101 27,431 108,705 Municipal securities 973 — (11 ) 962 — 166 796 Mortgage- and asset-backed securities 19,966 9 (506 ) 19,469 — 435 19,034 Subtotal 254,181 274 (3,600 ) 250,855 29,383 42,186 179,286 Total $ 270,657 $ 274 $ (3,705 ) $ 267,226 $ 45,059 $ 42,881 $ 179,286 September 30, 2017 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 7,982 $ — $ — $ 7,982 $ 7,982 $ — $ — Level 1 (1) : Money market funds 6,534 — — 6,534 6,534 — — Mutual funds 799 — (88 ) 711 — 711 — Subtotal 7,333 — (88 ) 7,245 6,534 711 — Level 2 (2) : U.S. Treasury securities 55,254 58 (230 ) 55,082 865 17,228 36,989 U.S. agency securities 5,162 2 (9 ) 5,155 1,439 2,057 1,659 Non-U.S. government securities 7,827 210 (37 ) 8,000 9 123 7,868 Certificates of deposit and time deposits 5,832 — — 5,832 1,142 3,918 772 Commercial paper 3,640 — — 3,640 2,146 1,494 — Corporate securities 152,724 969 (242 ) 153,451 172 27,591 125,688 Municipal securities 961 4 (1 ) 964 — 114 850 Mortgage- and asset-backed securities 21,684 35 (175 ) 21,544 — 656 20,888 Subtotal 253,084 1,278 (694 ) 253,668 5,773 53,181 194,714 Total $ 268,399 $ 1,278 $ (782 ) $ 268,895 $ 20,289 $ 53,892 $ 194,714 (1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities. (2) Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
Marketable Securities in a Continuous Unrealized Loss Position | The following tables show information about the Company’s marketable securities that had been in a continuous unrealized loss position for less than 12 months and for 12 months or greater as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Continuous Unrealized Losses Less than 12 Months 12 Months or Greater Total Fair value of marketable securities $ 159,198 $ 37,266 $ 196,464 Unrealized losses $ (2,633 ) $ (1,072 ) $ (3,705 ) September 30, 2017 Continuous Unrealized Losses Less than 12 Months 12 Months or Greater Total Fair value of marketable securities $ 101,986 $ 8,290 $ 110,276 Unrealized losses $ (596 ) $ (186 ) $ (782 ) |
Derivative Instruments at Gross Fair Value | The following tables show the Company’s derivative instruments at gross fair value as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) : Foreign exchange contracts $ 1,361 $ 290 $ 1,651 Interest rate contracts $ 12 $ — $ 12 Derivative liabilities (2) : Foreign exchange contracts $ 651 $ 514 $ 1,165 Interest rate contracts $ 1,052 $ — $ 1,052 September 30, 2017 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) : Foreign exchange contracts $ 1,049 $ 363 $ 1,412 Interest rate contracts $ 218 $ — $ 218 Derivative liabilities (2) : Foreign exchange contracts $ 759 $ 501 $ 1,260 Interest rate contracts $ 303 $ — $ 303 (1) The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets and other non-current assets in the Condensed Consolidated Balance Sheets. (2) The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses and other non-current liabilities in the Condensed Consolidated Balance Sheets. |
Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges | The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Gains/(Losses) recognized in OCI – effective portion: Cash flow hedges: Foreign exchange contracts $ 37 $ (317 ) $ 190 $ 1,410 Interest rate contracts — 2 1 9 Total $ 37 $ (315 ) $ 191 $ 1,419 Net investment hedges: Foreign currency debt $ (33 ) $ (85 ) $ (31 ) $ 37 Gains/(Losses) reclassified from AOCI into net income – effective portion: Cash flow hedges: Foreign exchange contracts $ 287 $ 1,344 $ 163 $ 833 Interest rate contracts 2 (2 ) 3 (3 ) Total $ 289 $ 1,342 $ 166 $ 830 Gains/(Losses) on derivative instruments: Fair value hedges: Interest rate contracts $ (674 ) $ (50 ) $ (948 ) $ (922 ) Gains/(Losses) related to hedged items: Fair value hedges: Fixed-rate debt $ 674 $ 50 $ 948 $ 922 |
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments | The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 31, 2018 and September 30, 2017 (in millions): March 31, 2018 September 30, 2017 Notional Amount Credit Risk Amount Notional Amount Credit Risk Amount Instruments designated as accounting hedges: Foreign exchange contracts $ 48,122 $ 1,361 $ 56,156 $ 1,049 Interest rate contracts $ 35,250 $ 12 $ 33,000 $ 218 Instruments not designated as accounting hedges: Foreign exchange contracts $ 61,179 $ 290 $ 69,774 $ 363 |
Condensed Consolidated Financ21
Condensed Consolidated Financial Statement Details (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Inventories | Inventories March 31, September 30, Components $ 5,186 $ 3,025 Finished goods 2,476 1,830 Total inventories $ 7,662 $ 4,855 |
Property, Plant and Equipment, Net | Property, Plant and Equipment, Net March 31, September 30, Land and buildings $ 14,931 $ 13,587 Machinery, equipment and internal-use software 57,784 54,210 Leasehold improvements 7,787 7,279 Gross property, plant and equipment 80,502 75,076 Accumulated depreciation and amortization (45,425 ) (41,293 ) Total property, plant and equipment, net $ 35,077 $ 33,783 |
Other Non-Current Liabilities | Other Non-Current Liabilities March 31, September 30, Long-term taxes payable $ 34,913 $ 257 Deferred tax liabilities 548 31,504 Other non-current liabilities 11,394 8,654 Total other non-current liabilities $ 46,855 $ 40,415 |
Other Income/(Expense), Net | Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Interest and dividend income $ 1,505 $ 1,282 $ 2,957 $ 2,506 Interest expense (792 ) (530 ) (1,526 ) (1,055 ) Other expense, net (439 ) (165 ) (401 ) (43 ) Total other income/(expense), net $ 274 $ 587 $ 1,030 $ 1,408 |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Debt Disclosure [Abstract] | |
Summary of Cash Flows Associated with Issuance and Maturities of Commercial Paper | The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 31, 2018 and April 1, 2017 (in millions): Six Months Ended March 31, April 1, Maturities 90 days or less: Proceeds from/(Repayments of) commercial paper, net $ 4,070 $ (1,318 ) Maturities greater than 90 days: Proceeds from commercial paper 5,550 7,057 Repayments of commercial paper (9,619 ) (3,860 ) Proceeds from/(Repayments of) commercial paper, net (4,069 ) 3,197 Total change in commercial paper, net $ 1 $ 1,879 |
Summary of Term Debt | The following table provides a summary of the Company’s term debt as of March 31, 2018 and September 30, 2017 : Maturities March 31, 2018 September 30, 2017 Amount (in millions) Effective Interest Rate Amount (in millions) Effective Interest Rate 2013 debt issuance of $17.0 billion: Floating-rate notes 2018 2018 $ 2,000 1.10% 1.10 % $ 2,000 1.10% 1.10 % Fixed-rate 1.000% – 3.850% notes 2018 – 2043 12,500 1.08% – 3.91 % 12,500 1.08% – 3.91 % 2014 debt issuance of $12.0 billion: Floating-rate notes 2019 2019 1,000 2.09% 2.09 % 1,000 1.61% 1.61 % Fixed-rate 2.100% – 4.450% notes 2019 – 2044 8,500 2.09% – 4.48 % 8,500 1.61% – 4.48 % 2015 debt issuances of $27.3 billion: Floating-rate notes 2019 – 2020 1,537 1.87% – 2.12 % 1,549 1.56% – 1.87 % Fixed-rate 0.350% – 4.375% notes 2019 – 2045 25,094 0.28% – 4.51 % 24,522 0.28% – 4.51 % 2016 debt issuances of $24.9 billion: Floating-rate notes 2019 – 2021 1,350 1.93% – 3.05 % 1,350 1.45% – 2.44 % Fixed-rate 1.100% – 4.650% notes 2019 – 2046 23,120 1.13% – 4.78 % 23,645 1.13% – 4.78 % 2017 debt issuances of $28.7 billion: Floating-rate notes 2019 – 2022 3,250 1.88% – 2.30 % 3,250 1.38% – 1.81 % Fixed-rate 0.875% – 4.300% notes 2019 – 2047 25,786 1.54% – 4.30 % 25,705 1.51% – 4.30 % First quarter 2018 debt issuance of $7.0 billion: Fixed-rate 1.800% notes 2019 1,000 1.83 % — — % Fixed-rate 2.000% notes 2020 1,000 2.03 % — — % Fixed-rate 2.400% notes 2023 750 2.14 % — — % Fixed-rate 2.750% notes 2025 1,500 2.77 % — — % Fixed-rate 3.000% notes 2027 1,500 2.54 % — — % Fixed-rate 3.750% notes 2047 1,250 3.80 % — — % Total term debt 111,137 104,021 Unamortized premium/(discount) and issuance costs, net (236 ) (225 ) Hedge accounting fair value adjustments (1,041 ) (93 ) Less: Current portion of long-term debt (8,498 ) (6,496 ) Total long-term debt $ 101,362 $ 97,207 |
Shareholders' Equity (Tables)
Shareholders' Equity (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Equity [Abstract] | |
Accelerated Share Repurchase Activity and Related Information | The following table shows the Company’s ASR activity and related information during the six months ended March 31, 2018 and the year ended September 30, 2017 : Purchase Period End Date Number of Shares (in thousands) Average Repurchase Price Per Share ASR Amount (in millions) November 2017 ASR February 2018 29,269 (1) $ 170.84 $ 5,000 August 2017 ASR November 2017 18,887 $ 158.84 $ 3,000 May 2017 ASR August 2017 20,108 $ 149.20 $ 3,000 February 2017 ASR May 2017 20,949 $ 143.20 $ 3,000 November 2016 ASR February 2017 51,157 $ 117.29 $ 6,000 August 2016 ASR November 2016 26,850 $ 111.73 $ 3,000 (1) Includes 23.6 million shares delivered and retired at the beginning of the purchase period, which began in the first quarter of 2018, and 5.7 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2018. |
Repurchases of Common Shares in the Open Market | Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: Number of Shares (in thousands) Average Repurchase Price Per Share Amount (in millions) 2018: Second quarter 137,040 $ 171.48 $ 23,500 First quarter 30,181 $ 169.26 5,109 Total open market common stock repurchases 167,221 $ 28,609 2017: Fourth quarter 29,073 $ 154.78 $ 4,500 Third quarter 30,356 $ 148.24 4,500 Second quarter 31,070 $ 128.74 4,001 First quarter 44,333 $ 112.78 5,000 Total open market common stock repurchases 134,832 $ 18,001 |
Comprehensive Income (Tables)
Comprehensive Income (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Equity [Abstract] | |
Pre-tax Amounts Reclassified from AOCI into the Condensed Consolidated Statements of Operations | The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended Comprehensive Income Components Financial Statement Line Item March 31, April 1, March 31, April 1, Unrealized (gains)/losses on derivative instruments: Foreign exchange contracts Net sales $ 87 $ (408 ) $ 271 $ (509 ) Cost of sales 21 (570 ) (6 ) (557 ) Other income/(expense), net (390 ) (367 ) (423 ) 237 Interest rate contracts Other income/(expense), net (2 ) 2 (3 ) 3 (284 ) (1,343 ) (161 ) (826 ) Unrealized (gains)/losses on marketable securities Other income/(expense), net 36 (20 ) (80 ) 11 Total amounts reclassified from AOCI $ (248 ) $ (1,363 ) $ (241 ) $ (815 ) |
Changes in AOCI by Component | The following table shows the changes in AOCI by component for the six months ended March 31, 2018 (in millions): Cumulative Foreign Currency Translation Unrealized Gains/Losses on Derivative Instruments Unrealized Gains/Losses on Marketable Securities Total Balances as of September 30, 2017 $ (354 ) $ (124 ) $ 328 $ (150 ) Other comprehensive income/(loss) before reclassifications 296 191 (3,854 ) (3,367 ) Amounts reclassified from AOCI — (161 ) (80 ) (241 ) Tax effect 7 (74 ) 1,039 972 Other comprehensive income/(loss) 303 (44 ) (2,895 ) (2,636 ) Cumulative effect of change in accounting principle (1) (176 ) 29 (131 ) (278 ) Balances as of March 31, 2018 $ (227 ) $ (139 ) $ (2,698 ) $ (3,064 ) (1) Refer to Note 4, “Income Taxes” for more information on the Company’s adoption of ASU 2018-02 at the beginning of the second quarter of 2018. |
Benefit Plans (Tables)
Benefit Plans (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Restricted Stock Unit Activity | A summary of the Company’s RSU activity and related information for the six months ended March 31, 2018 is as follows: Number of RSUs (in thousands) Weighted-Average Grant Date Fair Value Per RSU Aggregate Fair Value (in millions) Balance as of September 30, 2017 97,571 $ 110.33 RSUs granted 40,184 $ 159.25 RSUs vested (22,348 ) $ 103.66 RSUs canceled (3,023 ) $ 123.28 Balance as of March 31, 2018 112,384 $ 128.80 $ 18,856 |
Summary of Share-Based Compensation Expense | The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Cost of sales $ 257 $ 217 $ 509 $ 446 Research and development 666 575 1,312 1,164 Selling, general and administrative 425 425 823 863 Total share-based compensation expense $ 1,348 $ 1,217 $ 2,644 $ 2,473 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Changes in Accrued Warranties and Related Costs | The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Beginning accrued warranty and related costs $ 4,323 $ 4,698 $ 3,834 $ 3,702 Cost of warranty claims (933 ) (1,031 ) (1,915 ) (2,368 ) Accruals for product warranty 640 1,068 2,111 3,401 Ending accrued warranty and related costs $ 4,030 $ 4,735 $ 4,030 $ 4,735 |
Segment Information and Geogr27
Segment Information and Geographic Data (Tables) | 6 Months Ended |
Mar. 31, 2018 | |
Segment Reporting [Abstract] | |
Summary Information by Reportable Segment | The following table shows information by reportable segment for the three- and six-month periods ended March 31, 2018 and April 1, 2017 (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Americas: Net sales $ 24,841 $ 21,157 $ 60,034 $ 53,125 Operating income $ 7,768 $ 6,668 $ 19,084 $ 17,162 Europe: Net sales $ 13,846 $ 12,733 $ 34,900 $ 31,254 Operating income $ 4,259 $ 3,851 $ 11,152 $ 9,587 Greater China: Net sales $ 13,024 $ 10,726 $ 30,980 $ 26,959 Operating income $ 4,963 $ 4,224 $ 11,871 $ 10,400 Japan: Net sales $ 5,468 $ 4,485 $ 12,705 $ 10,251 Operating income $ 2,346 $ 2,037 $ 5,428 $ 4,710 Rest of Asia Pacific: Net sales $ 3,958 $ 3,795 $ 10,811 $ 9,658 Operating income $ 1,278 $ 1,309 $ 3,853 $ 3,538 |
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations | A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 31, 2018 and April 1, 2017 is as follows (in millions): Three Months Ended Six Months Ended March 31, April 1, March 31, April 1, Segment operating income $ 20,614 $ 18,089 $ 51,388 $ 45,397 Research and development expense (3,378 ) (2,776 ) (6,785 ) (5,647 ) Other corporate expenses, net (1,342 ) (1,216 ) (2,435 ) (2,294 ) Total operating income $ 15,894 $ 14,097 $ 42,168 $ 37,456 |
Summary of Significant Accoun28
Summary of Significant Accounting Policies - Additional Information (Details) $ in Millions | 6 Months Ended |
Apr. 01, 2017USD ($) | |
Accounting Standards Update 2016-09 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Increase to cash provided by operating activities | $ 225 |
Summary of Significant Accoun29
Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Numerator: | ||||
Net income | $ 13,822 | $ 11,029 | $ 33,887 | $ 28,920 |
Denominator: | ||||
Weighted-average basic shares outstanding (in shares) | 5,024,877 | 5,225,791 | 5,068,877 | 5,262,226 |
Effect of dilutive securities (in shares) | 43,616 | 35,897 | 44,263 | 32,615 |
Weighted-average diluted shares (in shares) | 5,068,493 | 5,261,688 | 5,113,140 | 5,294,841 |
Basic earnings per share (in dollars per share) | $ 2.75 | $ 2.11 | $ 6.69 | $ 5.50 |
Diluted earnings per share (in dollars per share) | $ 2.73 | $ 2.10 | $ 6.63 | $ 5.46 |
Financial Instruments - Cash, C
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 | Apr. 01, 2017 | Sep. 24, 2016 |
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | $ 270,657 | $ 268,399 | ||
Unrealized Gains | 274 | 1,278 | ||
Unrealized Losses | (3,705) | (782) | ||
Fair Value | 267,226 | 268,895 | ||
Cash and Cash Equivalents | 45,059 | 20,289 | $ 15,157 | $ 20,484 |
Short-Term Marketable Securities | 42,881 | 53,892 | ||
Long-Term Marketable Securities | 179,286 | 194,714 | ||
Cash | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 9,934 | 7,982 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | 0 | 0 | ||
Fair Value | 9,934 | 7,982 | ||
Cash and Cash Equivalents | 9,934 | 7,982 | ||
Short-Term Marketable Securities | 0 | 0 | ||
Long-Term Marketable Securities | 0 | 0 | ||
Level 1 | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 6,542 | 7,333 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | (105) | (88) | ||
Fair Value | 6,437 | 7,245 | ||
Cash and Cash Equivalents | 5,742 | 6,534 | ||
Short-Term Marketable Securities | 695 | 711 | ||
Long-Term Marketable Securities | 0 | 0 | ||
Level 1 | Money market funds | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 5,742 | 6,534 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | 0 | 0 | ||
Fair Value | 5,742 | 6,534 | ||
Cash and Cash Equivalents | 5,742 | 6,534 | ||
Short-Term Marketable Securities | 0 | 0 | ||
Long-Term Marketable Securities | 0 | 0 | ||
Level 1 | Mutual funds | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 800 | 799 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | (105) | (88) | ||
Fair Value | 695 | 711 | ||
Cash and Cash Equivalents | 0 | 0 | ||
Short-Term Marketable Securities | 695 | 711 | ||
Long-Term Marketable Securities | 0 | 0 | ||
Level 2 | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 254,181 | 253,084 | ||
Unrealized Gains | 274 | 1,278 | ||
Unrealized Losses | (3,600) | (694) | ||
Fair Value | 250,855 | 253,668 | ||
Cash and Cash Equivalents | 29,383 | 5,773 | ||
Short-Term Marketable Securities | 42,186 | 53,181 | ||
Long-Term Marketable Securities | 179,286 | 194,714 | ||
Level 2 | U.S. Treasury securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 56,737 | 55,254 | ||
Unrealized Gains | 1 | 58 | ||
Unrealized Losses | (932) | (230) | ||
Fair Value | 55,806 | 55,082 | ||
Cash and Cash Equivalents | 6,379 | 865 | ||
Short-Term Marketable Securities | 9,106 | 17,228 | ||
Long-Term Marketable Securities | 40,321 | 36,989 | ||
Level 2 | U.S. agency securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 5,539 | 5,162 | ||
Unrealized Gains | 0 | 2 | ||
Unrealized Losses | (39) | (9) | ||
Fair Value | 5,500 | 5,155 | ||
Cash and Cash Equivalents | 2,837 | 1,439 | ||
Short-Term Marketable Securities | 588 | 2,057 | ||
Long-Term Marketable Securities | 2,075 | 1,659 | ||
Level 2 | Non-U.S. government securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 8,247 | 7,827 | ||
Unrealized Gains | 88 | 210 | ||
Unrealized Losses | (137) | (37) | ||
Fair Value | 8,198 | 8,000 | ||
Cash and Cash Equivalents | 0 | 9 | ||
Short-Term Marketable Securities | 477 | 123 | ||
Long-Term Marketable Securities | 7,721 | 7,868 | ||
Level 2 | Certificates of deposit and time deposits | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 7,266 | 5,832 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | 0 | 0 | ||
Fair Value | 7,266 | 5,832 | ||
Cash and Cash Equivalents | 4,611 | 1,142 | ||
Short-Term Marketable Securities | 2,021 | 3,918 | ||
Long-Term Marketable Securities | 634 | 772 | ||
Level 2 | Commercial paper | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 17,417 | 3,640 | ||
Unrealized Gains | 0 | 0 | ||
Unrealized Losses | 0 | 0 | ||
Fair Value | 17,417 | 3,640 | ||
Cash and Cash Equivalents | 15,455 | 2,146 | ||
Short-Term Marketable Securities | 1,962 | 1,494 | ||
Long-Term Marketable Securities | 0 | 0 | ||
Level 2 | Corporate securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 138,036 | 152,724 | ||
Unrealized Gains | 176 | 969 | ||
Unrealized Losses | (1,975) | (242) | ||
Fair Value | 136,237 | 153,451 | ||
Cash and Cash Equivalents | 101 | 172 | ||
Short-Term Marketable Securities | 27,431 | 27,591 | ||
Long-Term Marketable Securities | 108,705 | 125,688 | ||
Level 2 | Municipal securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 973 | 961 | ||
Unrealized Gains | 0 | 4 | ||
Unrealized Losses | (11) | (1) | ||
Fair Value | 962 | 964 | ||
Cash and Cash Equivalents | 0 | 0 | ||
Short-Term Marketable Securities | 166 | 114 | ||
Long-Term Marketable Securities | 796 | 850 | ||
Level 2 | Mortgage- and asset-backed securities | ||||
Schedule of Available-for-sale Securities [Line Items] | ||||
Adjusted Cost | 19,966 | 21,684 | ||
Unrealized Gains | 9 | 35 | ||
Unrealized Losses | (506) | (175) | ||
Fair Value | 19,469 | 21,544 | ||
Cash and Cash Equivalents | 0 | 0 | ||
Short-Term Marketable Securities | 435 | 656 | ||
Long-Term Marketable Securities | $ 19,034 | $ 20,888 |
Financial Instruments - Additio
Financial Instruments - Additional Information (Details) $ in Millions | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Mar. 31, 2018USD ($)VendorCustomer | Apr. 01, 2017USD ($) | Mar. 31, 2018USD ($)VendorCustomer | Apr. 01, 2017USD ($) | Sep. 30, 2017USD ($)VendorCustomer | |
Financial Instruments [Line Items] | |||||
Maturities of long-term marketable securities, minimum | 1 year | ||||
Maturities of long-term marketable securities, maximum | 5 years | ||||
Hedged interest rate transactions, expected recognition period | 10 years | ||||
Potential reduction to derivative assets resulting from rights of set-off under master netting arrangements | $ 2,100 | $ 2,100 | $ 1,400 | ||
Potential reduction to derivative liabilities resulting from rights of set-off under master netting arrangements | 2,100 | 2,100 | 1,400 | ||
Net derivative assets/(liabilities) after potential reductions under master netting arrangements | $ (313) | $ (313) | $ 32 | ||
Trade receivables | Credit concentration risk | |||||
Financial Instruments [Line Items] | |||||
Number of customers that individually represented 10% or more of total trade receivables | Customer | 0 | 0 | 2 | ||
Trade receivables | Credit concentration risk | Customer one | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 10.00% | ||||
Trade receivables | Credit concentration risk | Customer two | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 10.00% | ||||
Trade receivables | Credit concentration risk | Cellular network carriers | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 48.00% | 59.00% | |||
Non-trade receivables | Credit concentration risk | |||||
Financial Instruments [Line Items] | |||||
Number of vendors that individually represented 10% or more of total vendor non-trade receivables | Vendor | 3 | 3 | 3 | ||
Non-trade receivables | Credit concentration risk | Vendor one | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 44.00% | 42.00% | |||
Non-trade receivables | Credit concentration risk | Vendor two | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 20.00% | 19.00% | |||
Non-trade receivables | Credit concentration risk | Vendor three | |||||
Financial Instruments [Line Items] | |||||
Concentration risk, percentage | 11.00% | 10.00% | |||
Other current assets | |||||
Financial Instruments [Line Items] | |||||
Net cash collateral posted, derivative instruments | $ 241 | $ 241 | |||
Accrued expenses | |||||
Financial Instruments [Line Items] | |||||
Net cash collateral received, derivative instruments | $ 35 | ||||
Derivatives not designated as accounting hedges | Net sales | |||||
Financial Instruments [Line Items] | |||||
Non-designated derivatives, fair value adjustment gains/(losses) | (203) | $ (67) | (142) | $ 206 | |
Derivatives not designated as accounting hedges | Cost of sales | |||||
Financial Instruments [Line Items] | |||||
Non-designated derivatives, fair value adjustment gains/(losses) | (247) | (253) | (212) | 79 | |
Derivatives not designated as accounting hedges | Other income/(expense), net | |||||
Financial Instruments [Line Items] | |||||
Non-designated derivatives, fair value adjustment gains/(losses) | $ (331) | $ (76) | $ (373) | $ 432 | |
Hedges of foreign currency exposure associated with revenue and inventory purchases | |||||
Financial Instruments [Line Items] | |||||
Hedged foreign currency transactions, expected recognition period | 12 months | ||||
Hedges of foreign currency exposure associated with term debt | |||||
Financial Instruments [Line Items] | |||||
Hedged foreign currency transactions, expected recognition period | 24 years |
Financial Instruments - Marketa
Financial Instruments - Marketable Securities in a Continuous Unrealized Loss Position (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Fair Value of Marketable Securities | ||
Continuous Unrealized Losses, Less than 12 Months | $ 159,198 | $ 101,986 |
Continuous Unrealized Losses, 12 Months or Greater | 37,266 | 8,290 |
Continuous Unrealized Losses, Total | 196,464 | 110,276 |
Unrealized Losses | ||
Continuous Unrealized Losses, Less than 12 Months | (2,633) | (596) |
Continuous Unrealized Losses, 12 Months or Greater | (1,072) | (186) |
Continuous Unrealized Losses, Total | $ (3,705) | $ (782) |
Financial Instruments - Derivat
Financial Instruments - Derivative Instruments at Gross Fair Value (Details) - Level 2 - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Other current assets and other non-current assets | Foreign exchange contracts | ||
Derivative assets: | ||
Fair value of derivative assets | $ 1,651 | $ 1,412 |
Other current assets and other non-current assets | Interest rate contracts | ||
Derivative assets: | ||
Fair value of derivative assets | 12 | 218 |
Other current assets and other non-current assets | Derivatives designated as accounting hedges | Foreign exchange contracts | ||
Derivative assets: | ||
Fair value of derivative assets | 1,361 | 1,049 |
Other current assets and other non-current assets | Derivatives designated as accounting hedges | Interest rate contracts | ||
Derivative assets: | ||
Fair value of derivative assets | 12 | 218 |
Other current assets and other non-current assets | Derivatives not designated as accounting hedges | Foreign exchange contracts | ||
Derivative assets: | ||
Fair value of derivative assets | 290 | 363 |
Other current assets and other non-current assets | Derivatives not designated as accounting hedges | Interest rate contracts | ||
Derivative assets: | ||
Fair value of derivative assets | 0 | 0 |
Accrued expenses and other non-current liabilities | Foreign exchange contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | 1,165 | 1,260 |
Accrued expenses and other non-current liabilities | Interest rate contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | 1,052 | 303 |
Accrued expenses and other non-current liabilities | Derivatives designated as accounting hedges | Foreign exchange contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | 651 | 759 |
Accrued expenses and other non-current liabilities | Derivatives designated as accounting hedges | Interest rate contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | 1,052 | 303 |
Accrued expenses and other non-current liabilities | Derivatives not designated as accounting hedges | Foreign exchange contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | 514 | 501 |
Accrued expenses and other non-current liabilities | Derivatives not designated as accounting hedges | Interest rate contracts | ||
Derivative liabilities: | ||
Fair value of derivative liabilities | $ 0 | $ 0 |
Financial Instruments - Pre-Tax
Financial Instruments - Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Hedges (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Cash flow hedges | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | $ 37 | $ (315) | $ 191 | $ 1,419 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | 289 | 1,342 | 166 | 830 |
Cash flow hedges | Foreign exchange contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | 37 | (317) | 190 | 1,410 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | 287 | 1,344 | 163 | 833 |
Cash flow hedges | Interest rate contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | 0 | 2 | 1 | 9 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | 2 | (2) | 3 | (3) |
Net investment hedges | Foreign currency debt | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | (33) | (85) | (31) | 37 |
Fair value hedges | Interest rate contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) on derivative instruments | (674) | (50) | (948) | (922) |
Gains/(Losses) related to hedged fixed-rate debt | $ 674 | $ 50 | $ 948 | $ 922 |
Financial Instruments - Notiona
Financial Instruments - Notional Amounts and Credit Risk Amounts Associated with Derivative Instruments (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Derivatives designated as accounting hedges | Foreign exchange contracts | ||
Derivative [Line Items] | ||
Derivative, notional amount | $ 48,122 | $ 56,156 |
Derivative, credit risk amount | 1,361 | 1,049 |
Derivatives designated as accounting hedges | Interest rate contracts | ||
Derivative [Line Items] | ||
Derivative, notional amount | 35,250 | 33,000 |
Derivative, credit risk amount | 12 | 218 |
Derivatives not designated as accounting hedges | Foreign exchange contracts | ||
Derivative [Line Items] | ||
Derivative, notional amount | 61,179 | 69,774 |
Derivative, credit risk amount | $ 290 | $ 363 |
Condensed Consolidated Financ36
Condensed Consolidated Financial Statement Details - Inventories (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Components | $ 5,186 | $ 3,025 |
Finished goods | 2,476 | 1,830 |
Total inventories | $ 7,662 | $ 4,855 |
Condensed Consolidated Financ37
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | $ 80,502 | $ 75,076 |
Accumulated depreciation and amortization | (45,425) | (41,293) |
Total property, plant and equipment, net | 35,077 | 33,783 |
Land and buildings | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | 14,931 | 13,587 |
Machinery, equipment and internal-use software | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | 57,784 | 54,210 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | $ 7,787 | $ 7,279 |
Condensed Consolidated Financ38
Condensed Consolidated Financial Statement Details - Other Non-Current Liabilities (Details) - USD ($) $ in Millions | Mar. 31, 2018 | Sep. 30, 2017 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Long-term taxes payable | $ 34,913 | $ 257 |
Deferred tax liabilities | 548 | 31,504 |
Other non-current liabilities | 11,394 | 8,654 |
Total other non-current liabilities | $ 46,855 | $ 40,415 |
Condensed Consolidated Financ39
Condensed Consolidated Financial Statement Details - Other Income/(Expense), Net (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Interest and dividend income | $ 1,505 | $ 1,282 | $ 2,957 | $ 2,506 |
Interest expense | (792) | (530) | (1,526) | (1,055) |
Other expense, net | (439) | (165) | (401) | (43) |
Total other income/(expense), net | $ 274 | $ 587 | $ 1,030 | $ 1,408 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) $ in Millions, € in Billions | Jan. 01, 2018 | Dec. 31, 2017 | Aug. 30, 2016EUR (€)Subsidiary | Mar. 31, 2018USD ($) | Dec. 30, 2017USD ($) | Apr. 01, 2017USD ($) | Mar. 31, 2018USD ($) | Apr. 01, 2017USD ($) | Sep. 30, 2017USD ($) |
Income Tax Contingency [Line Items] | |||||||||
U.S. statutory federal income tax rate | 21.00% | 35.00% | |||||||
Income tax expense | $ 2,346 | $ 3,655 | $ 9,311 | $ 9,944 | |||||
Provision for income taxes related to the Act, provisional amount | $ 2,600 | ||||||||
Provision for income taxes related to remeasurement of deferred tax balances, provisional amount | 1,800 | ||||||||
Provision for income taxes related to deemed repatriation tax, provisional amount | 800 | ||||||||
Deferred tax liability for unremitted foreign earnings | $ 36,400 | ||||||||
Deferred tax liability reversal | 34,235 | $ (2,822) | |||||||
Deemed repatriation tax payable, provisional amount | 38,000 | ||||||||
Gross unrecognized tax benefits | 9,500 | 9,500 | |||||||
Unrecognized tax benefits that would affect effective tax rate, if recognized | 8,200 | 8,200 | |||||||
Unrecognized tax benefits, gross interest and penalties accrued | 1,500 | 1,500 | |||||||
Reasonably possible decrease in gross unrecognized tax benefits over next 12 months | 3,400 | 3,400 | |||||||
Unfavorable investigation outcome, EU State Aid rules | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Number of subsidiaries impacted by European Commission tax ruling | Subsidiary | 2 | ||||||||
Maximum potential loss related to European Commission tax ruling | € | € 13 | ||||||||
Unfavorable investigation outcome, EU State Aid rules - interest component | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Maximum potential loss related to European Commission tax ruling | € | € 1 | ||||||||
Accumulated Other Comprehensive Income/(Loss) | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Reclassification from AOCI to retained earnings, tax effects of the Act | $ (278) | ||||||||
Accounting Standards Update 2018-02 | Accumulated Other Comprehensive Income/(Loss) | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Reclassification from AOCI to retained earnings, tax effects of the Act | (278) | ||||||||
Accounting Standards Update 2018-02 | Retained Earnings | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Reclassification from AOCI to retained earnings, tax effects of the Act | $ 278 | ||||||||
Tax Cuts and Jobs Act, deemed repatriation tax, related amount | |||||||||
Income Tax Contingency [Line Items] | |||||||||
Deferred tax liability reversal | 36,100 | ||||||||
Reduction of unrecognized tax benefits | $ 1,100 |
Debt - Additional Information (
Debt - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | Sep. 30, 2017 | |
Debt Instrument [Line Items] | |||||
Commercial paper | $ 11,980 | $ 11,980 | $ 11,977 | ||
Commercial paper, general maturity period (less than) | 9 months | ||||
Commercial paper, weighted-average interest rate | 1.68% | 1.68% | 1.20% | ||
Floating- and fixed-rate notes, aggregate principal amount | $ 111,137 | $ 111,137 | $ 104,021 | ||
Interest expense on term debt | 742 | $ 507 | 1,400 | $ 1,000 | |
Level 2 | |||||
Debt Instrument [Line Items] | |||||
Floating- and fixed-rate notes, aggregate fair value | 111,100 | 111,100 | 106,100 | ||
Net investment hedges | |||||
Debt Instrument [Line Items] | |||||
Carrying value of debt designated as a net investment hedge | $ 518 | $ 518 | $ 1,600 |
Debt - Summary of Cash Flows As
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($) $ in Millions | 6 Months Ended | |
Mar. 31, 2018 | Apr. 01, 2017 | |
Maturities 90 days or less: | ||
Proceeds from/(Repayments of) commercial paper, net | $ 4,070 | $ (1,318) |
Maturities greater than 90 days: | ||
Proceeds from commercial paper | 5,550 | 7,057 |
Repayments of commercial paper | (9,619) | (3,860) |
Proceeds from/(Repayments of) commercial paper, net | (4,069) | 3,197 |
Total change in commercial paper, net | $ 1 | $ 1,879 |
Debt - Summary of Term Debt (De
Debt - Summary of Term Debt (Details) - USD ($) | 6 Months Ended | |
Mar. 31, 2018 | Sep. 30, 2017 | |
Debt Instrument [Line Items] | ||
Total term debt | $ 111,137,000,000 | $ 104,021,000,000 |
Unamortized premium/(discount) and issuance costs, net | (236,000,000) | (225,000,000) |
Hedge accounting fair value adjustments | (1,041,000,000) | (93,000,000) |
Less: Current portion of long-term debt | (8,498,000,000) | (6,496,000,000) |
Total long-term debt | 101,362,000,000 | 97,207,000,000 |
2013 debt issuance of $17.0 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | 17,000,000,000 | |
2013 debt issuance of $17.0 billion | Floating-rate notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 2,000,000,000 | $ 2,000,000,000 |
Debt instrument, maturity year, start | 2,018 | |
Debt instrument, maturity year, end | 2,018 | |
2013 debt issuance of $17.0 billion | Floating-rate notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 1.10% | 1.10% |
2013 debt issuance of $17.0 billion | Floating-rate notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 1.10% | 1.10% |
2013 debt issuance of $17.0 billion | Fixed-rate 1.000% – 3.850% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 12,500,000,000 | $ 12,500,000,000 |
Debt instrument, maturity year, start | 2,018 | |
Debt instrument, maturity year, end | 2,043 | |
2013 debt issuance of $17.0 billion | Fixed-rate 1.000% – 3.850% notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 1.00% | |
Debt instrument, effective interest rate | 1.08% | 1.08% |
2013 debt issuance of $17.0 billion | Fixed-rate 1.000% – 3.850% notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 3.85% | |
Debt instrument, effective interest rate | 3.91% | 3.91% |
2014 debt issuance of $12.0 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 12,000,000,000 | |
2014 debt issuance of $12.0 billion | Floating-rate notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,000,000,000 | $ 1,000,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,019 | |
2014 debt issuance of $12.0 billion | Floating-rate notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 2.09% | 1.61% |
2014 debt issuance of $12.0 billion | Floating-rate notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 2.09% | 1.61% |
2014 debt issuance of $12.0 billion | Fixed-rate 2.100% – 4.450% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 8,500,000,000 | $ 8,500,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,044 | |
2014 debt issuance of $12.0 billion | Fixed-rate 2.100% – 4.450% notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 2.10% | |
Debt instrument, effective interest rate | 2.09% | 1.61% |
2014 debt issuance of $12.0 billion | Fixed-rate 2.100% – 4.450% notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 4.45% | |
Debt instrument, effective interest rate | 4.48% | 4.48% |
2015 debt issuances of $27.3 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 27,300,000,000 | |
2015 debt issuances of $27.3 billion | Floating-rate notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,537,000,000 | $ 1,549,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,020 | |
2015 debt issuances of $27.3 billion | Floating-rate notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 1.87% | 1.56% |
2015 debt issuances of $27.3 billion | Floating-rate notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 2.12% | 1.87% |
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 25,094,000,000 | $ 24,522,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,045 | |
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 0.35% | |
Debt instrument, effective interest rate | 0.28% | 0.28% |
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 4.375% | |
Debt instrument, effective interest rate | 4.51% | 4.51% |
2016 debt issuances of $24.9 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 24,900,000,000 | |
2016 debt issuances of $24.9 billion | Floating-rate notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,350,000,000 | $ 1,350,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,021 | |
2016 debt issuances of $24.9 billion | Floating-rate notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 1.93% | 1.45% |
2016 debt issuances of $24.9 billion | Floating-rate notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 3.05% | 2.44% |
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 23,120,000,000 | $ 23,645,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,046 | |
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 1.10% | |
Debt instrument, effective interest rate | 1.13% | 1.13% |
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 4.65% | |
Debt instrument, effective interest rate | 4.78% | 4.78% |
2017 debt issuances of $28.7 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 28,700,000,000 | |
2017 debt issuances of $28.7 billion | Floating-rate notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 3,250,000,000 | $ 3,250,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,022 | |
2017 debt issuances of $28.7 billion | Floating-rate notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 1.88% | 1.38% |
2017 debt issuances of $28.7 billion | Floating-rate notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, effective interest rate | 2.30% | 1.81% |
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 25,786,000,000 | $ 25,705,000,000 |
Debt instrument, maturity year, start | 2,019 | |
Debt instrument, maturity year, end | 2,047 | |
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes | Minimum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 0.875% | |
Debt instrument, effective interest rate | 1.54% | 1.51% |
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes | Maximum | ||
Debt Instrument [Line Items] | ||
Debt instrument, stated interest rate | 4.30% | |
Debt instrument, effective interest rate | 4.30% | 4.30% |
First quarter 2018 debt issuance of $7.0 billion | ||
Debt Instrument [Line Items] | ||
Debt instrument, face amount | $ 7,000,000,000 | |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 1.800% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,000,000,000 | $ 0 |
Debt instrument, maturity year | 2,019 | |
Debt instrument, stated interest rate | 1.80% | |
Debt instrument, effective interest rate | 1.83% | 0.00% |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 2.000% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,000,000,000 | $ 0 |
Debt instrument, maturity year | 2,020 | |
Debt instrument, stated interest rate | 2.00% | |
Debt instrument, effective interest rate | 2.03% | 0.00% |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 2.400% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 750,000,000 | $ 0 |
Debt instrument, maturity year | 2,023 | |
Debt instrument, stated interest rate | 2.40% | |
Debt instrument, effective interest rate | 2.14% | 0.00% |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 2.750% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,500,000,000 | $ 0 |
Debt instrument, maturity year | 2,025 | |
Debt instrument, stated interest rate | 2.75% | |
Debt instrument, effective interest rate | 2.77% | 0.00% |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 3.000% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,500,000,000 | $ 0 |
Debt instrument, maturity year | 2,027 | |
Debt instrument, stated interest rate | 3.00% | |
Debt instrument, effective interest rate | 2.54% | 0.00% |
First quarter 2018 debt issuance of $7.0 billion | Fixed-rate 3.750% notes | ||
Debt Instrument [Line Items] | ||
Total term debt | $ 1,250,000,000 | $ 0 |
Debt instrument, maturity year | 2,047 | |
Debt instrument, stated interest rate | 3.75% | |
Debt instrument, effective interest rate | 3.80% | 0.00% |
Shareholders' Equity - Addition
Shareholders' Equity - Additional Information (Details) - USD ($) | May 01, 2018 | Mar. 31, 2018 |
$210 billion share repurchase program in effect as of March 31, 2018 | ||
Stock Repurchase Program [Line Items] | ||
Maximum amount authorized for repurchase of common stock | $ 210,000,000,000 | |
Share repurchase program, amount utilized | $ 199,600,000,000 | |
$100 billion share repurchase program announced on May 1, 2018 | Subsequent event | ||
Stock Repurchase Program [Line Items] | ||
Maximum amount authorized for repurchase of common stock | $ 100,000,000,000 |
Shareholders' Equity - Accelera
Shareholders' Equity - Accelerated Share Repurchase Activity and Related Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 4 Months Ended | ||||||
Mar. 31, 2018 | Dec. 30, 2017 | Feb. 28, 2018 | Nov. 30, 2017 | Aug. 31, 2017 | May 31, 2017 | Feb. 28, 2017 | Nov. 30, 2016 | |
November 2017 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2018-02 | |||||||
Number of shares repurchased (in shares) | 5,700 | 23,600 | 29,269 | |||||
Average repurchase price per share (in dollars per share) | $ 170.84 | |||||||
ASR amount | $ 5,000 | |||||||
August 2017 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2017-11 | |||||||
Number of shares repurchased (in shares) | 18,887 | |||||||
Average repurchase price per share (in dollars per share) | $ 158.84 | |||||||
ASR amount | $ 3,000 | |||||||
May 2017 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2017-08 | |||||||
Number of shares repurchased (in shares) | 20,108 | |||||||
Average repurchase price per share (in dollars per share) | $ 149.20 | |||||||
ASR amount | $ 3,000 | |||||||
February 2017 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2017-05 | |||||||
Number of shares repurchased (in shares) | 20,949 | |||||||
Average repurchase price per share (in dollars per share) | $ 143.20 | |||||||
ASR amount | $ 3,000 | |||||||
November 2016 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2017-02 | |||||||
Number of shares repurchased (in shares) | 51,157 | |||||||
Average repurchase price per share (in dollars per share) | $ 117.29 | |||||||
ASR amount | $ 6,000 | |||||||
August 2016 ASR | ||||||||
Accelerated Share Repurchases [Line Items] | ||||||||
ASR purchase period end date | 2016-11 | |||||||
Number of shares repurchased (in shares) | 26,850 | |||||||
Average repurchase price per share (in dollars per share) | $ 111.73 | |||||||
ASR amount | $ 3,000 |
Shareholders' Equity - Repurcha
Shareholders' Equity - Repurchases of Common Shares in the Open Market (Details) - Open market repurchases - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
Mar. 31, 2018 | Dec. 30, 2017 | Sep. 30, 2017 | Jul. 01, 2017 | Apr. 01, 2017 | Dec. 31, 2016 | Mar. 31, 2018 | Sep. 30, 2017 | |
Stock Repurchase Program [Line Items] | ||||||||
Number of shares repurchased (in shares) | 137,040 | 30,181 | 29,073 | 30,356 | 31,070 | 44,333 | 167,221 | 134,832 |
Average repurchase price per share (in dollars per share) | $ 171.48 | $ 169.26 | $ 154.78 | $ 148.24 | $ 128.74 | $ 112.78 | ||
Amount | $ 23,500 | $ 5,109 | $ 4,500 | $ 4,500 | $ 4,001 | $ 5,000 | $ 28,609 | $ 18,001 |
Comprehensive Income - Pre-tax
Comprehensive Income - Pre-tax Amounts Reclassified from AOCI into the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Net sales | $ (61,137) | $ (52,896) | $ (149,430) | $ (131,247) |
Cost of sales | 37,715 | 32,305 | 92,096 | 80,480 |
Other income/(expense), net | (274) | (587) | (1,030) | (1,408) |
Total amounts reclassified from AOCI | (16,168) | (14,684) | (43,198) | (38,864) |
Reclassifications out of AOCI | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total amounts reclassified from AOCI | (248) | (1,363) | (241) | (815) |
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total amounts reclassified from AOCI | (284) | (1,343) | (161) | (826) |
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments | Foreign exchange contracts | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Net sales | 87 | (408) | 271 | (509) |
Cost of sales | 21 | (570) | (6) | (557) |
Other income/(expense), net | (390) | (367) | (423) | 237 |
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments | Interest rate contracts | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Other income/(expense), net | (2) | 2 | (3) | 3 |
Reclassifications out of AOCI | Unrealized (gains)/losses on marketable securities | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Other income/(expense), net | $ 36 | $ (20) | $ (80) | $ 11 |
Comprehensive Income - Change i
Comprehensive Income - Change in AOCI by Component (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balances as of September 30, 2017 | $ 134,047 | |||
Total other comprehensive income/(loss) | $ (1,945) | $ (667) | (2,636) | $ (1,056) |
Balances as of March 31, 2018 | 126,878 | 126,878 | ||
Cumulative Foreign Currency Translation | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balances as of September 30, 2017 | (354) | |||
Other comprehensive income/(loss) before reclassifications | 296 | |||
Amounts reclassified from AOCI | 0 | |||
Tax effect | 7 | |||
Total other comprehensive income/(loss) | 303 | |||
Cumulative effect of change in accounting principle | (176) | |||
Balances as of March 31, 2018 | (227) | (227) | ||
Unrealized Gains/Losses on Derivative Instruments | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balances as of September 30, 2017 | (124) | |||
Other comprehensive income/(loss) before reclassifications | 191 | |||
Amounts reclassified from AOCI | (161) | |||
Tax effect | (74) | |||
Total other comprehensive income/(loss) | (44) | |||
Cumulative effect of change in accounting principle | 29 | |||
Balances as of March 31, 2018 | (139) | (139) | ||
Unrealized Gains/Losses on Marketable Securities | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balances as of September 30, 2017 | 328 | |||
Other comprehensive income/(loss) before reclassifications | (3,854) | |||
Amounts reclassified from AOCI | (80) | |||
Tax effect | 1,039 | |||
Total other comprehensive income/(loss) | (2,895) | |||
Cumulative effect of change in accounting principle | (131) | |||
Balances as of March 31, 2018 | (2,698) | (2,698) | ||
Total AOCI | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balances as of September 30, 2017 | (150) | |||
Other comprehensive income/(loss) before reclassifications | (3,367) | |||
Amounts reclassified from AOCI | (241) | |||
Tax effect | 972 | |||
Total other comprehensive income/(loss) | (2,636) | |||
Cumulative effect of change in accounting principle | (278) | |||
Balances as of March 31, 2018 | $ (3,064) | $ (3,064) |
Benefit Plans - Additional Info
Benefit Plans - Additional Information (Details) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018USD ($)shares | Apr. 01, 2017USD ($) | Mar. 31, 2018USD ($)shares | Apr. 01, 2017USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares reserved for future issuance under stock plans (in shares) | shares | 270,000,000 | 270,000,000 | ||
Income tax benefit related to share-based compensation expense | $ 347 | $ 424 | $ 1,000 | $ 889 |
Total unrecognized compensation cost related to RSUs and stock options | 11,400 | $ 11,400 | ||
Total unrecognized compensation cost related to RSUs and stock options, weighted-average recognition period | 2 years 9 months | |||
Restricted stock units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
RSUs granted, vesting period | 4 years | |||
Number of shares of common stock issued per RSU upon vesting | 1 | |||
Reduction in number of shares available for grant per share issued with respect to RSUs granted (in shares) | shares | 2 | |||
Factor by which each RSU canceled or share withheld for taxes increases the number of shares available for grant | 2 | |||
Fair value of vested RSUs as of vesting date | $ 457 | $ 460 | $ 3,600 | $ 2,600 |
Benefit Plans - Restricted Stoc
Benefit Plans - Restricted Stock Units Activity and Related Information (Details) - Restricted stock units $ / shares in Units, shares in Thousands, $ in Millions | 6 Months Ended |
Mar. 31, 2018USD ($)$ / sharesshares | |
Number of Restricted Stock Units | |
Beginning balance (in shares) | shares | 97,571 |
RSUs granted (in shares) | shares | 40,184 |
RSUs vested (in shares) | shares | (22,348) |
RSUs canceled (in shares) | shares | (3,023) |
Ending balance (in shares) | shares | 112,384 |
Weighted-Average Grant Date Fair Value Per RSU | |
Beginning balance (in dollars per share) | $ / shares | $ 110.33 |
RSUs granted (in dollars per share) | $ / shares | 159.25 |
RSUs vested (in dollars per share) | $ / shares | 103.66 |
RSUs canceled (in dollars per share) | $ / shares | 123.28 |
Ending balance (in dollars per share) | $ / shares | $ 128.80 |
Aggregate Fair Value | |
Aggregate fair value of restricted stock units | $ | $ 18,856 |
Benefit Plans - Summary of Shar
Benefit Plans - Summary of Share-Based Compensation Expense (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | $ 1,348 | $ 1,217 | $ 2,644 | $ 2,473 |
Cost of sales | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | 257 | 217 | 509 | 446 |
Research and development | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | 666 | 575 | 1,312 | 1,164 |
Selling, general and administrative | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | $ 425 | $ 425 | $ 823 | $ 863 |
Commitments and Contingencies -
Commitments and Contingencies - Changes in Accrued Warranties and Related Costs (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Changes in Accrued Warranties and Related Costs [Roll Forward] | ||||
Beginning accrued warranty and related costs | $ 4,323 | $ 4,698 | $ 3,834 | $ 3,702 |
Cost of warranty claims | (933) | (1,031) | (1,915) | (2,368) |
Accruals for product warranty | 640 | 1,068 | 2,111 | 3,401 |
Ending accrued warranty and related costs | $ 4,030 | $ 4,735 | $ 4,030 | $ 4,735 |
Commitments and Contingencies53
Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions | Apr. 11, 2018 | Sep. 30, 2016 | Mar. 31, 2018 |
Commitments and Contingencies Disclosure [Line Items] | |||
Purchase commitments, period (up to) | 150 days | ||
Total future minimum lease payments under noncancelable operating leases | $ 9,800 | ||
Typical term of leases (not exceeding) | 10 years | ||
Unconditional purchase obligations | $ 8,300 | ||
VirnetX I | Pending litigation | |||
Commitments and Contingencies Disclosure [Line Items] | |||
Award from legal proceeding, due to other party | $ 302 | ||
Award from legal proceeding, due to other party, revised amount, determined in subsequent proceedings | $ 440 | ||
VirnetX II | Pending litigation | Subsequent event | |||
Commitments and Contingencies Disclosure [Line Items] | |||
Award from legal proceeding, due to other party | $ 503 |
Segment Information and Geogr54
Segment Information and Geographic Data - Summary Information by Reportable Segment (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Segment Reporting Information [Line Items] | ||||
Net sales | $ 61,137 | $ 52,896 | $ 149,430 | $ 131,247 |
Operating income | 15,894 | 14,097 | 42,168 | 37,456 |
Americas | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 24,841 | 21,157 | 60,034 | 53,125 |
Operating income | 7,768 | 6,668 | 19,084 | 17,162 |
Europe | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 13,846 | 12,733 | 34,900 | 31,254 |
Operating income | 4,259 | 3,851 | 11,152 | 9,587 |
Greater China | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 13,024 | 10,726 | 30,980 | 26,959 |
Operating income | 4,963 | 4,224 | 11,871 | 10,400 |
Japan | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 5,468 | 4,485 | 12,705 | 10,251 |
Operating income | 2,346 | 2,037 | 5,428 | 4,710 |
Rest of Asia Pacific | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 3,958 | 3,795 | 10,811 | 9,658 |
Operating income | $ 1,278 | $ 1,309 | $ 3,853 | $ 3,538 |
Segment Information and Geogr55
Segment Information and Geographic Data - Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Mar. 31, 2018 | Apr. 01, 2017 | Mar. 31, 2018 | Apr. 01, 2017 | |
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Operating income | $ 15,894 | $ 14,097 | $ 42,168 | $ 37,456 |
Research and development expense | (3,378) | (2,776) | (6,785) | (5,647) |
Operating segments | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Operating income | 20,614 | 18,089 | 51,388 | 45,397 |
Segment reconciling items | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Research and development expense | (3,378) | (2,776) | (6,785) | (5,647) |
Corporate non-segment | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Other corporate expenses, net | $ (1,342) | $ (1,216) | $ (2,435) | $ (2,294) |